Clal Biotechnology reported ILS-857K in Gross Profit on Sales for its fiscal quarter ending in June of 2022.





Gross Profit On Sales Change Date
aTyr Pharma USD 190K 15.57M Sep/2025
Clal Biotechnology ILS -857K 1.42M Jun/2022
Compugen USD 241K 649K Sep/2025
RedHill Biopharma USD 584K 0 Jun/2024